Tuesday Morning Articles of Interest

It’s Tuesday and this is what I’m reading:

  • Recalls happen every day and cost a lot of money, there is a way to insure against that financial loss, but few companies know about it or insure against it – Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of Valsartan and Valsartan Hydrochlorothiazide Tablets (Business Wire).
  • 4 Regulations That Would Terrify U.S. Drug Companies Ahead Of The 2018 Midterms (Forbes).
  • Another stark warning over CRISPR/Cas9’s potential to do lasting harm dents share prices (Endpoints).
  • How medtech can prepare for the consequences of a “Hard Brexit” (Medical Design & Outsourcing).

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s